# Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

> **NCT00531687** · PHASE2 · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 8 (actual)

## Conditions studied

- Testicular Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00531687
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2012-02
- **Final completion:** 2016-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531687, "Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00531687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*